Significant Ownership of Lara Sullivan
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Lara Sullivan focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Lara Sullivan - Lara Sullivan, President,Chief Executive Officer & Chief Medical Officer
- Manager location
- Rockville, MD
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Lara Sullivan with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Lara Sullivan
Significant Ownership of Lara Sullivan
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PYXS | Pyxis Oncology, Inc. | Common Stock, par value $0.001 per share | 11% | $7,844,727 | +$955,040 | 7,543,007 | +14% | Lara Sullivan, M.D. | 31 Mar 2025 |
Schedules 13D/G Reported by Lara Sullivan:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.